Rare diseases
Investigational molecules
Locations
101 Rue De Tolbiac, 75013 Paris, France
Clinical research in HIV-1 focuses on post-treatment viral control, immune-based strategies, and maintenance of suppression in people living with HIV. The sponsor supports studies in primary infection, chronic infection, and treatment simplification, with attention to sustained virological success and interruption of standard therapy under controlled conditions.
Research also includes immune-modulating approaches intended to shape viral persistence and support longer-term remission in treated populations.
ANRS Maladies Infectieuses Emergentes runs clinical trials in conditions such as HIV infection, Hepatitis B virus test, Hepatitis B e antigen negative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
